The Transitions in Cognitive and Functional Status of People with Mild-Moderate Alzheimer's Disease Treated by Galantamine: A Retrospective Study

The intern’s project aims to investigate how cognitive and functional abilities of patients treated for mild/moderate Alzheimer’s disease (AD) change over time. Despite of neurodegenerative nature of AD, these changes might occur in every direction. According to our preliminary investigation, both improvement and worsening are possible. We will compare the long-term changes during 48 months of the follow-up and identify the probabilities of any change over a short-term (1 year) and a longer-term (4 years) follow-up.

Melanie Abeysundera
Faculty Supervisor: 
Dr. Arnold Mitnitski
Nova Scotia